Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phosphorus and FGF 23 in Dent Disease
NCT02016235Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2014
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of phosphorus in Dent disease, nephrolithiasis, sponsored by Mayo Clinic. Started Sep 2014; status: completed.
02
Drugs
phosphorus
03
Conditions
Dent diseasenephrolithiasis
Beyond the preview
Go deeper on NCT02016235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016235.